pharma · Phenylketonuria · Amyotrophic Lateral Sclerosis · PTCT
PTC THERAPEUTICS
PTC THERAPEUTICS, INC.
PTC THERAPEUTICS is a pharma organization headquartered in WARREN, NJ, USA. It trades on NYSE under ticker PTCT. Primary therapeutic focus areas include Phenylketonuria, Amyotrophic Lateral Sclerosis, Cystic Fibrosis, Du
500 Warren Corporate Center Drive, Warren, NJ 07059, US HQ
1998 Founded
1,153 Employees
Public company Type
PTCT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 500 Warren Corporate Center Drive, Warren, NJ 07059, US
- Founded
- 1998
- Employees
- 1,153
- Programs
- 52
- Drugs
- 21
- Patents
- 149
VEGF inhibitor PTC299
Phase 2 · small molecule · Kaposi's Sarcoma
VEGF inhibitor PTC299 for Kaposi's Sarcoma is a Phase 2 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Internal code AMC-059
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- PTC THERAPEUTICS, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Kaposi's Sarcoma
- Status
- terminated
- Trials
- 1